Psychiatry and Neurology, Neurology · Jacksonville, FL
NPI
1861461964
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
11525 Village Crossing Dr Ste 1101
Jacksonville, FL, 32256
Phone (904) 730-3689
Groups this clinician bills Medicare through
Medicare paid, 2024
$488K
53,900 services
Medicare patients, 2024
1,043
Average age 76
Drug cost, 2024
$3.1M
6,640 prescriptions
Company payments, 2025
$63K
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Zhigao Huang was code J0585 (injection, onabotulinumtoxina, 1 unit), 45,215 times for 88 patients. In total Zhigao Huang billed 53,900 services in 29 codes, and Medicare paid $488K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 45,215 | 88 | $4.87 | $220K |
| J0587 Injection, rimabotulinumtoxinb, 100 units | Office | 3,360 | 35 | $10.08 | $34K |
| 99214 Office E&M - Established | Office | 599 | 398 | $91.68 | $55K |
| 99215 Office E&M - Established | Office | 261 | 205 | $140.74 | $37K |
| 99232 Hospital E&M - Subsequent | Facility | 185 | 130 | $64.47 | $12K |
| 64616 Musculoskeletal | Office | 145 | 50 | $153.15 | $22K |
| 99222 Hospital E&M - Initial | Facility | 141 | 139 | $107.18 | $15K |
| 99213 Office E&M - Established | Office | 129 | 104 | $66.52 | $8,581 |
| 99204 Office E&M - New | Office | 127 | 127 | $128.40 | $16K |
| 95983 Electrical Nerve Conductivity | Office | 118 | 43 | $39.23 | $4,629 |
| 64611 Musculoskeletal | Office | 87 | 35 | $104.49 | $9,091 |
| 64612 Musculoskeletal | Office | 81 | 26 | $140.21 | $11K |
| 99205 Office E&M - New | Office | 58 | 58 | $171.60 | $9,953 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 55 | 55 | $10.10 | $556 |
| 99204 Office E&M - New | Facility | 46 | 46 | $100.58 | $4,627 |
By year: 2022 $468K for 52,832 services; 2023 $452K for 50,302 services; 2024 $488K for 53,900 services.
Medicare prescription drug claims, 2024
In 2024, the drug Zhigao Huang prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 1,272 prescriptions and refills. In total Zhigao Huang wrote 6,640 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 1,272 | 3,200 | 348 | $48K |
| Donepezil Hcl Generic | 361 | 855 | 115 | $4,099 |
| Quetiapine Fumarate Generic | 348 | 711 | 100 | $5,607 |
| Escitalopram Oxalate Generic | 297 | 716 | 90 | $4,784 |
| Clonazepam Generic | 297 | 361 | 59 | $2,057 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 279 | 767 | 82 | $10K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 259 | 662 | 81 | $12K |
| Primidone Generic | 190 | 429 | 59 | $6,283 |
| Botox Onabotulinumtoxina | 161 | 449 | 55 | $181K |
| Gabapentin Generic | 156 | 389 | 55 | $3,364 |
| Gocovri Amantadine Hcl | 152 | 202 | 23 | $430K |
| Sertraline Hcl Generic | 150 | 324 | 52 | $1,272 |
| Amantadine Amantadine Hcl | 141 | 391 | 47 | $9,410 |
| Propranolol Hcl Generic | 127 | 315 | 45 | $2,728 |
| Mirtazapine Generic | 120 | 235 | 29 | $3,133 |
Brand drugs: 869 claims; generic drugs: 5,771 claims; opioid claims: 29.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Zhigao Huang $63K ($63K in general payments such as food, travel and fees) from 28 companies. The largest payer was MDD US Operations, LLC with $39K.
| Company | Payments | Amount |
|---|---|---|
| MDD US Operations, LLC | 37 | $39K |
| Teva Pharmaceuticals USA, Inc. TEVA | 31 | $20K |
| Abbvie Inc. ABBV | 50 | $865 |
| Amneal Pharmaceuticals LLC AMRX | 6 | $214 |
| Neurocrine BioSciences, Inc. NBIX | 4 | $191 |
| ACADIA Pharmaceuticals Inc ACAD | 7 | $152 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $150 |
| SK Life Science, Inc. | 1 | $135 |
| TG Therapeutics, Inc. TGTX | 1 | $126 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $125 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.